Co-Authors
This is a "connection" page, showing publications co-authored by Bugra Kerget and Ferhan Kerget.
Connection Strength
3.580
-
Frequency of Interleukin-6 rs1800795 (-174G/C) and rs1800797 (-597G/A) Polymorphisms in COVID-19 Patients in Turkey Who Develop Macrophage Activation Syndrome. Jpn J Infect Dis. 2021 Nov 22; 74(6):543-548.
Score: 0.943
-
Evaluation of the relationship between laboratory parameters and pulmonary function tests in COVID-19 patients. Int J Clin Pract. 2021 Jul; 75(7):e14237.
Score: 0.942
-
Evaluation of the relationship between TREM-1/TREM-2 ratio and clinical course in COVID-19 pneumonia. Int J Clin Pract. 2021 Oct; 75(10):e14697.
Score: 0.240
-
Is endogenous carboxyhaemoglobin level a useful biomarker of clinical course and prognosis in COVID-19 patients? Int J Clin Pract. 2021 Nov; 75(11):e14680.
Score: 0.240
-
Evaluation of the relationship between pentraxin 3 (PTX3) rs2305619 (281A/G) and rs1840680 (1449A/G) polymorphisms and the clinical course of COVID-19. J Med Virol. 2021 Dec; 93(12):6653-6659.
Score: 0.240
-
Evaluation of the relationship between KIM-1 and suPAR levels and clinical severity in COVID-19 patients: A different perspective on suPAR. J Med Virol. 2021 Sep; 93(9):5568-5573.
Score: 0.237
-
Evaluation of alpha defensin, IL-1 receptor antagonist, and IL-18 levels in COVID-19 patients with macrophage activation syndrome and acute respiratory distress syndrome. J Med Virol. 2021 04; 93(4):2090-2098.
Score: 0.228
-
Are Serum Interleukin 6 and Surfactant Protein D Levels Associated with the Clinical Course of COVID-19? Lung. 2020 10; 198(5):777-784.
Score: 0.226
-
Evaluation of the relationship of serum vitamin D levels in COVID-19 patients with clinical course and prognosis. Tuberk Toraks. 2020 Sep; 68(3):227-235.
Score: 0.225
-
Evaluation of the relationship between macrophage migration inhibitory factor level and clinical course in patients with COVID-19 pneumonia. J Med Virol. 2021 12; 93(12):6519-6524.
Score: 0.060